USCOM Parameters in Preterm Infants: Reference Ranges
Hemodynamic Evaluation in Preterm Babies Using UltraSonic Cardiac Output Monitor (USCOM)
1 other identifier
observational
80
1 country
1
Brief Summary
The goal of this observational study is to learn about the feasibility of hemodynamic measurement by the UltraSonic Cardiac Output Monitor (USCOM) in very preterm or very-low-birth-weight infants. The main questions it aims to answer are: 1) establishing reference ranges for USCOM parameters in this specific population, 2) assessing the effect of patients' characteristics and other possible confounders on USCOM parameters, and 3) evaluating the short-term repeatability of the measurement. Participants will receive USCOM measurements on 3, 7, and 14 postnatal days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 6, 2023
CompletedFirst Submitted
Initial submission to the registry
July 18, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedJuly 27, 2023
July 1, 2023
1 month
July 18, 2023
July 18, 2023
Conditions
Outcome Measures
Primary Outcomes (9)
Cardiac Output at 3 days
Cardiac Output measured by the USCOM system, normalized by body weight and expressed in ml/kg/min
3 ± 1 days of life
Cardiac Output at 7 days
Cardiac Output measured by the USCOM system, normalized by body weight and expressed in ml/kg/min
7 ± 2 days of life
Cardiac Output at 14 days
Cardiac Output measured by the USCOM system, normalized by body weight and expressed in ml/kg/min
14 ± 2 days of life
Cardiac Index at 3 days
Cardiac Output measured by the USCOM system normalized by body surface and expressed in L/min/m2
3 ± 1 days of life
Cardiac Index at 7 days
Cardiac Output measured by the USCOM system normalized by body surface and expressed in L/min/m2
7 ± 2 days of life
Cardiac Index at 14 days
Cardiac Output measured by the USCOM system normalized by body surface and expressed in L/min/m2
14 ± 2 days of life
Systemic Vascular Resistance Index at 3 days
Systemic Vascular Resistance measured by the USCOM system normalized by body surface and expressed in d\*s\*cm-5/m2
3 ± 1 days of life
Systemic Vascular Resistance Index at 7 days
Systemic Vascular Resistance measured by the USCOM system normalized by body surface and expressed in d\*s\*cm-5/m2
7 ± 2 days of life
Systemic Vascular Resistance Index at 14 days
Systemic Vascular Resistance measured by the USCOM system normalized by body surface and expressed in d\*s\*cm-5/m2
14 ± 2 days of life
Interventions
We will measure cardiac output, cardiac index, and systemic vascular resistance index on 3, 7, and 14 postnatal days using the UltraSonic Cardiac Output Monitor.
Eligibility Criteria
We include very preterm and/or very low birth weight infants without heart disease as assessed by echocardiography, who are considered hemodynamically stable by the attending physician and do not require drugs that might affect the cardiocirculatory function (e.g., inotropes).
You may qualify if:
- gestational age at birth below 32 weeks and/or
- birth weight (BW) below 1500 g
You may not qualify if:
- congenital heart diseases,
- hemodynamic instability requiring drugs that affect hemodynamics (e.g., inotropes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS San Gerardo dei Tintori
Monza, Monza E Brianza, 20900, Italy
Related Publications (4)
Doni D, Nucera S, Rigotti C, Arosio E, Cavalleri V, Ronconi M, Ventura ML, Fedeli T. Evaluation of hemodynamics in healthy term neonates using ultrasonic cardiac output monitor. Ital J Pediatr. 2020 Aug 5;46(1):112. doi: 10.1186/s13052-020-00872-x.
PMID: 32758264BACKGROUNDPatel N, Dodsworth M, Mills JF. Cardiac output measurement in newborn infants using the ultrasonic cardiac output monitor: an assessment of agreement with conventional echocardiography, repeatability and new user experience. Arch Dis Child Fetal Neonatal Ed. 2011 May;96(3):F206-11. doi: 10.1136/adc.2009.170704. Epub 2010 Jul 6.
PMID: 20605971BACKGROUNDFraga MV, Dysart KC, Rintoul N, Chaudhary AS, Ratcliffe SJ, Fedec A, Kren S, Cohen MS, Kirpalani H. Cardiac Output Measurement Using the Ultrasonic Cardiac Output Monitor: A Validation Study in Newborn Infants. Neonatology. 2019;116(3):260-268. doi: 10.1159/000501005. Epub 2019 Jul 19.
PMID: 31326967BACKGROUNDHe SR, Zhang C, Liu YM, Sun YX, Zhuang J, Chen JM, Madigan VM, Smith BE, Sun X. Accuracy of the ultrasonic cardiac output monitor in healthy term neonates during postnatal circulatory adaptation. Chin Med J (Engl). 2011 Aug;124(15):2284-9.
PMID: 21933558BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Daniela Doni, MD
Fondazione IRCCS San Gerardo dei Tintori
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Neonatologist
Study Record Dates
First Submitted
July 18, 2023
First Posted
July 27, 2023
Study Start
July 6, 2023
Primary Completion
August 9, 2023
Study Completion
September 1, 2023
Last Updated
July 27, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share